Journal of Bone Research
Open Access

Correlations of Osteoporosis in Patients with Parkinson's Disease

Peter Thompson^{* *}Correspondence: Peter Thompson, Department of Bone and Osteogenesis Imperfecta, Kennedy Krieger Institute, Baltimore, USA, Email:

Author info »

Description

Parkinson's Disease (PD) is a progressive neurodegenerative disorder that affects approximately 1% of the population over the age of 65. It is characterized by a loss of dopamine-producing neurons in the brain, leading to motor symptoms such as tremors, stiffness, and difficulty with movement. However, research has shown that PD is also associated with an increased risk of osteoporosis, a condition characterized by weakened bones and increased risk of fractures.

Correlations between PD and osteoporosis

Several studies have reported an increased risk of osteoporosis and fractures in patients with PD compared to age-matched controls. One study found that PD patients had a 2- to 3-fold increased risk of hip fracture compared to the general population. Another study found that PD patients had a significantly lower Bone Mineral Density (BMD) compared to healthy controls, which is a key factor in osteoporosis diagnosis.

Potential mechanisms

The mechanisms underlying the increased risk of osteoporosis in PD patients are not fully understood. However, several potential factors have been proposed, including:

Reduced physical activity: PD patients often experience decreased mobility and physical activity, which can lead to reduced bone density and increased risk of fractures.

Vitamin D deficiency: PD patients have been shown to have lower levels of vitamin D, a key nutrient for bone health. Low vitamin D levels have been linked to reduced bone density and increased fracture risk.

Medication side effects: Certain medications used to treat PD, such as dopamine agonists, have been associated with an increased risk of bone loss and fractures.

Neurological and hormonal factors: PD may affect the nervous system and hormones that regulate bone metabolism, leading to bone loss and increased fracture risk.

Management strategies

The management of osteoporosis in PD patients requires a multidisciplinary approach, including management of PD symptoms and bone health. Here are some potential strategies that may help prevent and manage osteoporosis in PD patients:

Exercise: Regular physical activity can help improve bone density and reduce fracture risk. Exercise programs tailored to the needs and abilities of PD patients can help improve mobility and reduce falls.

Vitamin D and calcium supplementation: PD patients should ensure they are getting adequate vitamin D and calcium, either through their diet or supplements, to support bone health.

Medication management: PD medications that have been linked to an increased risk of bone loss and fractures should be used with caution, and alternative medications may be considered.

Fall prevention: PD patients should take steps to prevent falls, such as removing tripping hazards in their homes, wearing proper footwear, and using mobility aids as needed.

The correlation between PD and osteoporosis is a growing area of research, and there is increasing evidence to support an increased risk of bone loss and fractures in PD patients. The mechanisms underlying this increased risk are not fully understood, but several potential factors have been proposed. Management of osteoporosis in PD patients requires a multidisciplinary approach, including exercise, vitamin D and calcium supplementation, medication management, and fall prevention strategies. Clinicians who treat PD patients should be aware of this increased risk and take steps to promote bone health and reduce fracture risk in their patients.